Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Rep ; 27(10): 2799-2808.e3, 2019 06 04.
Article in English | MEDLINE | ID: mdl-31167127

ABSTRACT

Reciprocal communication between neurons and oligodendrocytes is essential for the generation and localization of myelin, a critical feature of the CNS. In the neocortex, individual oligodendrocytes can myelinate multiple axons; however, the neuronal origin of the myelinated axons has remained undefined and, while largely assumed to be from excitatory pyramidal neurons, it also includes inhibitory interneurons. This raises the question of whether individual oligodendrocytes display bias for the class of neurons that they myelinate. Here, we find that different classes of cortical interneurons show distinct patterns of myelin distribution starting from the onset of myelination, suggesting that oligodendrocytes can recognize the class identity of individual types of interneurons that they target. Notably, we show that some oligodendrocytes disproportionately myelinate the axons of inhibitory interneurons, whereas others primarily target excitatory axons or show no bias. These results point toward very specific interactions between oligodendrocytes and neurons and raise the interesting question of why myelination is differentially directed toward different neuron types.


Subject(s)
Axons/metabolism , Myelin Sheath/physiology , Neocortex/physiology , Oligodendroglia/metabolism , Animals , Axons/physiology , Axons/ultrastructure , Female , Interneurons/cytology , Interneurons/metabolism , Interneurons/physiology , Interneurons/ultrastructure , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myelin Sheath/metabolism , Neocortex/metabolism , Neocortex/ultrastructure , Neural Inhibition , Oligodendroglia/cytology , Oligodendroglia/physiology , Oligodendroglia/ultrastructure , Pyramidal Cells/metabolism , Software
2.
J Physiol ; 593(19): 4373-86, 2015 Oct 01.
Article in English | MEDLINE | ID: mdl-26174503

ABSTRACT

KEY POINTS: The hippocampal CA1 region is highly vulnerable to ischaemic stroke. Two forms of AMPA receptor (AMPAR) plasticity - an anoxic form of long-term potentiation and a delayed increase in Ca(2+) -permeable (CP) AMPARs - contribute to this susceptibility by increasing excitotoxicity. In CA1, the acid-sensing ion channel 1a (ASIC1a) is known to facilitate LTP and contribute to ischaemic acidotoxicity. We have examined the role of ASIC1a in AMPAR ischaemic plasticity in organotypic hippocampal slice cultures exposed to oxygen glucose deprivation (a model of ischaemic stroke), and in hippocampal pyramidal neuron cultures exposed to acidosis. We find that ASIC1a activation promotes both forms of AMPAR plasticity and that neuroprotection, by inhibiting ASIC1a, circumvents any further benefit of blocking CP-AMPARs. Our observations establish a new interaction between acidotoxicity and excitotoxicity, and provide insight into the role of ASIC1a and CP-AMPARs in neurodegeneration. Specifically, we propose that ASIC1a activation drives certain post-ischaemic forms of CP-AMPAR plasticity. ABSTRACT: The CA1 region of the hippocampus is particularly vulnerable to ischaemic damage. While NMDA receptors play a major role in excitotoxicity, it is thought to be exacerbated in this region by two forms of post-ischaemic AMPA receptor (AMPAR) plasticity - namely, anoxic long-term potentiation (a-LTP), and a delayed increase in the prevalence of Ca(2+) -permeable GluA2-lacking AMPARs (CP-AMPARs). The acid-sensing ion channel 1a (ASIC1a), which is expressed in CA1 pyramidal neurons, is also known to contribute to post-ischaemic neuronal death and to physiologically induced LTP. This raises the question does ASIC1a activation drive the post-ischaemic forms of AMPAR plasticity in CA1 pyramidal neurons? We have tested this by examining organotypic hippocampal slice cultures (OHSCs) exposed to oxygen glucose deprivation (OGD), and dissociated cultures of hippocampal pyramidal neurons (HPNs) exposed to low pH (acidosis). We find that both a-LTP and the delayed increase in the prevalence of CP-AMPARs are dependent on ASIC1a activation during ischaemia. Indeed, acidosis alone is sufficient to induce the increase in CP-AMPARs. We also find that inhibition of ASIC1a channels circumvents any potential neuroprotective benefit arising from block of CP-AMPARs. By demonstrating that ASIC1a activation contributes to post-ischaemic AMPAR plasticity, our results identify a functional interaction between acidotoxicity and excitotoxicity in hippocampal CA1 cells, and provide insight into the role of ASIC1a and CP-AMPARs as potential drug targets for neuroprotection. We thus propose that ASIC1a activation can drive certain forms of CP-AMPAR plasticity, and that inhibiting ASIC1a affords neuroprotection.


Subject(s)
Acid Sensing Ion Channels/physiology , Acidosis/physiopathology , Brain Ischemia/physiopathology , CA1 Region, Hippocampal/physiology , Pyramidal Cells/physiology , Receptors, AMPA/physiology , Acid Sensing Ion Channels/genetics , Animals , Cells, Cultured , Excitatory Postsynaptic Potentials , Hypoglycemia/physiopathology , Hypoxia/physiopathology , Mice, Knockout , Rats, Wistar
3.
Nat Neurosci ; 18(5): 674-82, 2015 May.
Article in English | MEDLINE | ID: mdl-25821912

ABSTRACT

Diffuse white matter injury (DWMI), a leading cause of neurodevelopmental disabilities in preterm infants, is characterized by reduced oligodendrocyte formation. NG2-expressing oligodendrocyte precursor cells (NG2 cells) are exposed to various extrinsic regulatory signals, including the neurotransmitter GABA. We investigated GABAergic signaling to cerebellar white matter NG2 cells in a mouse model of DWMI (chronic neonatal hypoxia). We found that hypoxia caused a loss of GABAA receptor-mediated synaptic input to NG2 cells, extensive proliferation of these cells and delayed oligodendrocyte maturation, leading to dysmyelination. Treatment of control mice with a GABAA receptor antagonist or deletion of the chloride-accumulating transporter NKCC1 mimicked the effects of hypoxia. Conversely, blockade of GABA catabolism or GABA uptake reduced NG2 cell numbers and increased the formation of mature oligodendrocytes both in control and hypoxic mice. Our results indicate that GABAergic signaling regulates NG2 cell differentiation and proliferation in vivo, and suggest that its perturbation is a key factor in DWMI.


Subject(s)
Cerebellum/pathology , Demyelinating Diseases/etiology , Hypoxia, Brain/physiopathology , Neural Stem Cells/cytology , Neurogenesis/physiology , Oligodendroglia/cytology , Receptors, GABA-A/physiology , White Matter/injuries , gamma-Aminobutyric Acid/physiology , Action Potentials/drug effects , Animals , Animals, Newborn , Asphyxia Neonatorum/pathology , Carbachol/pharmacology , Cell Count , Cells, Cultured , Cerebellum/growth & development , Demyelinating Diseases/chemically induced , Disease Models, Animal , Female , GABA-A Receptor Antagonists/toxicity , Hypoxia, Brain/pathology , Interneurons/pathology , Male , Mice , Mice, Knockout , Mice, Transgenic , Neurogenesis/drug effects , Nipecotic Acids/pharmacology , Nipecotic Acids/therapeutic use , Purkinje Cells/pathology , Solute Carrier Family 12, Member 2/deficiency , Solute Carrier Family 12, Member 2/physiology , Tiagabine , Vigabatrin/pharmacology , Vigabatrin/therapeutic use
4.
J Neurosci ; 33(21): 8990-9002, 2013 May 22.
Article in English | MEDLINE | ID: mdl-23699510

ABSTRACT

The pathological mechanisms underlying neurological deficits observed in individuals born prematurely are not completely understood. A common form of injury in the preterm population is periventricular white matter injury (PWMI), a pathology associated with impaired brain development. To mitigate or eliminate PWMI, there is an urgent need to understand the pathological mechanism(s) involved on a neurobiological, structural, and functional level. Recent clinical data suggest that a percentage of premature infants experience relative hyperoxia. Using a hyperoxic model of premature brain injury, we have previously demonstrated that neonatal hyperoxia exposure in the mouse disrupts development of the white matter (WM) by delaying the maturation of the oligodendroglial lineage. In the present study, we address the question of how hyperoxia-induced alterations in WM development affect overall WM integrity and axonal function. We show that neonatal hyperoxia causes ultrastructural changes, including: myelination abnormalities (i.e., reduced myelin thickness and abnormal extramyelin loops) and axonopathy (i.e., altered neurofilament phosphorylation, paranodal defects, and changes in node of Ranvier number and structure). This disruption of axon-oligodendrocyte integrity results in the lasting impairment of conduction properties in the adult WM. Understanding the pathology of premature PWMI injury will allow for the development of interventional strategies to preserve WM integrity and function.


Subject(s)
Axons/pathology , Brain/pathology , Hyperoxia/pathology , Nerve Fibers, Myelinated/pathology , Oligodendroglia/pathology , 2',3'-Cyclic-Nucleotide Phosphodiesterases/genetics , 2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , Action Potentials/physiology , Age Factors , Animals , Animals, Newborn , Axons/ultrastructure , Disease Models, Animal , Female , Gene Expression Regulation, Developmental/physiology , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Microscopy, Electron, Transmission , Myelin-Associated Glycoprotein/genetics , Myelin-Associated Glycoprotein/metabolism , NAV1.6 Voltage-Gated Sodium Channel/genetics , NAV1.6 Voltage-Gated Sodium Channel/metabolism , Neurofilament Proteins/genetics , Neurofilament Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Oligodendroglia/ultrastructure
5.
J Neurosci ; 32(29): 9796-804, 2012 Jul 18.
Article in English | MEDLINE | ID: mdl-22815494

ABSTRACT

Ionotropic glutamate receptors, which underlie a majority of excitatory synaptic transmission in the CNS, associate with transmembrane proteins that modify their intracellular trafficking and channel gating. Significant advances have been made in our understanding of AMPA-type glutamate receptor (AMPAR) regulation by transmembrane AMPAR regulatory proteins. Less is known about the functional influence of cornichons-unrelated AMPAR-interacting proteins, identified by proteomic analysis. Here we confirm that cornichon homologs 2 and 3 (CNIH-2 and CNIH-3), but not CNIH-1, slow the deactivation and desensitization of both GluA2-containing calcium-impermeable and GluA2-lacking calcium-permeable (CP) AMPARs expressed in tsA201 cells. CNIH-2 and -3 also enhanced the glutamate sensitivity, single-channel conductance, and calcium permeability of CP-AMPARs while decreasing their block by intracellular polyamines. We examined the potential effects of CNIHs on native AMPARs by recording from rat optic nerve oligodendrocyte precursor cells (OPCs), known to express a significant population of CP-AMPARs. These glial cells exhibited surface labeling with an anti-CNIH-2/3 antibody. Two features of their AMPAR-mediated currents-the relative efficacy of the partial agonist kainate (I(KA)/I(Glu) ratio 0.4) and a greater than fivefold potentiation of kainate responses by cyclothiazide-suggest AMPAR association with CNIHs. Additionally, overexpression of CNIH-3 in OPCs markedly slowed AMPAR desensitization. Together, our experiments support the view that CNIHs are capable of altering key properties of AMPARs and suggest that they may do so in glia.


Subject(s)
Egg Proteins/metabolism , Membrane Proteins/metabolism , Neuroglia/metabolism , Neurons/metabolism , Receptors, AMPA/metabolism , Animals , Calcium/metabolism , Cell Line , Cells, Cultured , Egg Proteins/genetics , Excitatory Amino Acid Agonists/pharmacology , Female , Glutamic Acid/pharmacology , Humans , Ion Channel Gating/drug effects , Ion Channel Gating/genetics , Kainic Acid/pharmacology , Male , Membrane Proteins/genetics , Neuroglia/cytology , Neuroglia/drug effects , Neurons/cytology , Neurons/drug effects , Optic Nerve/cytology , Optic Nerve/drug effects , Optic Nerve/metabolism , Rats , Receptors, AMPA/genetics , Synaptic Transmission/drug effects , Synaptic Transmission/genetics , Transfection
6.
Nat Neurosci ; 14(11): 1430-8, 2011 Oct 09.
Article in English | MEDLINE | ID: mdl-21983683

ABSTRACT

Oligodendrocyte precursor cells (OPCs), a major glial cell type that gives rise to myelinating oligodendrocytes in the CNS, express calcium-permeable AMPA receptors (CP-AMPARs). Although CP-AMPARs are important for OPC proliferation and neuron-glia signaling, they render OPCs susceptible to ischemic damage in early development. We identified factors controlling the dynamic regulation of AMPAR subtypes in OPCs from rat optic nerve and mouse cerebellar cortex. We found that activation of group 1 mGluRs drove an increase in the proportion of CP-AMPARs, reflected by an increase in single-channel conductance and inward rectification. This plasticity required the elevation of intracellular calcium and used PI3K, PICK-1 and the JNK pathway. In white matter, neurons and astrocytes release both ATP and glutamate. Unexpectedly, activation of purinergic receptors in OPCs decreased CP-AMPAR expression, suggesting a capacity for homeostatic regulation. Finally, we found that stargazin-related transmembrane AMPAR regulatory proteins, which are critical for AMPAR surface expression in neurons, regulate CP-AMPAR plasticity in OPCs.


Subject(s)
Calcium/metabolism , Ion Channel Gating/physiology , Neuronal Plasticity/physiology , Oligodendroglia/physiology , Receptors, AMPA/metabolism , Animals , Animals, Newborn , Antigens/metabolism , Biophysical Phenomena/drug effects , Biophysical Phenomena/genetics , Biophysical Phenomena/physiology , Calcium Channels/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Cycle Proteins , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Lineage , Cerebellum/cytology , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Agents/pharmacology , Female , Galactosylceramidase/metabolism , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Glutamic Acid/pharmacology , Glycine Agents/pharmacology , In Vitro Techniques , Ion Channel Gating/drug effects , Luminescent Proteins/genetics , Male , Membrane Potentials/drug effects , Membrane Potentials/genetics , Methoxyhydroxyphenylglycol/analogs & derivatives , Methoxyhydroxyphenylglycol/pharmacology , Mice , Mice, Transgenic , Mutation/genetics , Neuronal Plasticity/genetics , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Oligodendroglia/cytology , Optic Nerve/cytology , Proteoglycans/metabolism , Rats , Receptors, AMPA/genetics , Signal Transduction/drug effects , Signal Transduction/genetics , Stem Cells/metabolism , Strychnine/pharmacology , Tetrodotoxin/pharmacology
7.
Nat Neurosci ; 12(3): 277-85, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19234459

ABSTRACT

Although the properties and trafficking of AMPA-type glutamate receptors (AMPARs) depend critically on associated transmembrane AMPAR regulatory proteins (TARPs) such as stargazin (gamma-2), no TARP has been described that can specifically regulate the important class of calcium-permeable (CP-) AMPARs. We examined the stargazin-related protein gamma-5, which is highly expressed in Bergmann glia, a cell type possessing only CP-AMPARs. gamma-5 was previously thought not to be a TARP, and it has been widely used as a negative control. Here we find that, contrary to expectation, gamma-5 acts as a TARP and serves this role in Bergmann glia. Whereas gamma-5 interacts with all AMPAR subunits, and modifies their behavior to varying extents, its main effect is to regulate the function of AMPAR subunit combinations that lack short-form subunits, which constitute predominantly CP-AMPARs. Our results suggest an important role for gamma-5 in regulating the functional contribution of CP-AMPARs.


Subject(s)
Calcium Signaling/physiology , Calcium/metabolism , Cell Membrane Permeability/physiology , Receptors, AMPA/classification , Receptors, AMPA/physiology , Animals , Calcium Channels/genetics , Calcium Channels/physiology , Calcium Signaling/genetics , Cell Line , Cell Membrane Permeability/genetics , Humans , Neuroglia/chemistry , Neuroglia/metabolism , Neuroglia/physiology , Protein Isoforms/genetics , Protein Isoforms/physiology , Protein Transport/genetics , Rats , Receptors, AMPA/genetics , Receptors, AMPA/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...